ADVERSE EFFECTS

You have access
Effect of Age on Rheumatic Immune-Related Adverse Events: Experience From the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)
Jenny Xiaoyu Li, Marie Hudson, Carrie Ye, Janet Roberts, Aurore Fifi-Mah, May Y. Choi, Sabrina Hoa, C. Thomas Appleton, Janet Pope, Nancy Maltez, Lourdes Gonzalez Arreola, Anthony Obrzut and Shahin Jamal on behalf of the Canadian Research Group of Rheumatology in Immuno-Oncology (CanRIO)

The Journal of Rheumatology April 1 2025, 52 (4) 389-395; DOI: https://doi.org/10.3899/jrheum.2024-0603
You have access
Immune Checkpoint Inhibitor–Associated Remitting Seronegative Symmetrical Synovitis With Pitting Edema: Description of a New Entity by CanRIO
Azin Rouhi, Shahin Jamal, Lourdes Gonzales Arreola, David Moon, Marie Hudson, Janet Roberts, Alexandra Ladouceur and Carrie Ye

The Journal of Rheumatology May 1 2024, 51 (5) 523-528; DOI: https://doi.org/10.3899/jrheum.2023-0969
Open Access
Safety of Guselkumab With and Without Prior Tumor Necrosis Factor Inhibitor Treatment: Pooled Results Across 4 Studies in Patients With Psoriatic Arthritis
Proton Rahman, Wolf-Henning Boehncke, Philip J. Mease, Alice B. Gottlieb, Iain B. McInnes, May Shawi, Yanli Wang, Shihong Sheng, Alexa P. Kollmeier, Elke Theander, Jenny Yu, Evan Leibowitz, A. Marilise Marrache and Laura C. Coates

The Journal of Rheumatology June 1 2023, 50 (6) 769-780; DOI: https://doi.org/10.3899/jrheum.220928
Open Access
Frequency of Symptomatic Adverse Events in Rheumatoid Arthritis: An Exploratory Online Survey
Glen S. Hazlewood, Orit Schieir, Vivian Bykerk, Kamso Mujaab, Peter Tugwell, George Wells, Dawn Richards, Laurie Proulx, Pauline M. Hull and Susan J. Bartlett

The Journal of Rheumatology September 1 2022, 49 (9) 998-1005; DOI: https://doi.org/10.3899/jrheum.210688
Open Access
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis
Proton Rahman, Christopher T. Ritchlin, Philip S. Helliwell, Wolf-Henning Boehncke, Philip J. Mease, Alice B. Gottlieb, Shelly Kafka, Alexa P. Kollmeier, Elizabeth C. Hsia, Xie L. Xu, May Shawi, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Paraneedharan Ramachandran, Yanli Zhuang and Iain B. McInnes

The Journal of Rheumatology December 1 2021, 48 (12) 1815-1823; DOI: https://doi.org/10.3899/jrheum.201532
Open Access
Longterm, Real-world Safety of Adalimumab in Rheumatoid Arthritis: Analysis of a Prospective US-based Registry
Leslie R. Harrold, Jenny Griffith, Patrick Zueger, Heather J. Litman, Bernice Gershenson, Syed S. Islam, Christine J. Barr, Dianlin Guo, Jonathan Fay and Jeffrey D. Greenberg

The Journal of Rheumatology July 1 2020, 47 (7) 959-967; DOI: https://doi.org/10.3899/jrheum.190260
You have access
Toward a Core Domain Set for Glucocorticoid Impact in Inflammatory Rheumatic Diseases: The OMERACT 2018 Glucocorticoid Impact Working Group
Jonathan T.L. Cheah, Rachel J. Black, Joanna C. Robson, Iris Y. Navarro-Millán, Sarah R. Young, Pamela Richards, Susan Beard, Lee S. Simon, Susan M. Goodman, Sarah L. Mackie and Catherine L. Hill

The Journal of Rheumatology September 1 2019, 46 (9) 1179-1182; DOI: https://doi.org/10.3899/jrheum.181082
You have access
Association Between Glucocorticoid Exposure and Healthcare Expenditures for Potential Glucocorticoid-related Adverse Events in Patients with Rheumatoid Arthritis
Jennie H. Best, Amanda M. Kong, Gregory M. Lenhart, Khaled Sarsour, Marni Stott-Miller and Yong Hwang

The Journal of Rheumatology March 1 2018, 45 (3) 320-328; DOI: https://doi.org/10.3899/jrheum.170418
You have access
A Patient-reported Outcome Measure for Effect of Glucocorticoid Therapy in Adults with Inflammatory Diseases Is Needed: Report from the OMERACT 2016 Special Interest Group
Rachel J. Black, Joanna C. Robson, Susan M. Goodman, Elizabeth Hoon, Lana Y.H. Lai, Lee S. Simon, Eileen Harrison, Lorna Neill, Pam Richards, Linda M. Nelsen, J. Michael Nebesky, Sarah L. Mackie and Catherine L. Hill

The Journal of Rheumatology November 1 2017, 44 (11) 1754-1758; DOI: https://doi.org/10.3899/jrheum.161083
You have access
Late-onset Neutropenia in Patients with Rheumatoid Arthritis after Treatment with Rituximab
Rita Abdulkader, Chethana Dharmapalaiah, Ginny Rose, Lynne M. Shand, Gavin P. Clunie and Richard A. Watts

The Journal of Rheumatology May 1 2014, 41 (5) 858-861; DOI: https://doi.org/10.3899/jrheum.130526

Main menu

User menu

Search

ADVERSE EFFECTS

Content

Resources

Subscribers

More